STEPHEN HAHN to Sarcoma
This is a "connection" page, showing publications STEPHEN HAHN has written about Sarcoma.
Connection Strength
0.619
-
A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis. Clin Cancer Res. 2006 Apr 15; 12(8):2517-25.
Score: 0.133
-
Patterns of recurrence in patients treated with photodynamic therapy for intraperitoneal carcinomatosis and sarcomatosis. Int J Oncol. 2004 Mar; 24(3):711-7.
Score: 0.115
-
Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicity. J Surg Oncol. 2020 Oct; 122(5):877-883.
Score: 0.089
-
A prospective study of proton reirradiation for recurrent and secondary soft tissue sarcoma. Radiother Oncol. 2017 08; 124(2):271-276.
Score: 0.072
-
Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection. J Surg Oncol. 2016 Jul; 114(1):65-9.
Score: 0.067
-
Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy. Clin Cancer Res. 2006 Sep 15; 12(18):5464-70.
Score: 0.034
-
EF5 binding and clinical outcome in human soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 2006 Mar 01; 64(3):922-7.
Score: 0.033
-
Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients. Clin Cancer Res. 2004 Jul 15; 10(14):4630-8.
Score: 0.029
-
Preliminary report of photodynamic therapy for intraperitoneal sarcomatosis. Ann Surg Oncol. 2001 Apr; 8(3):254-9.
Score: 0.023
-
Hypoxia in human intraperitoneal and extremity sarcomas. Int J Radiat Oncol Biol Phys. 2001 Feb 01; 49(2):587-96.
Score: 0.023